Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,239 public trials 881 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Recruiting

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

NCT05008809

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Klinikum St. Marien Amberg Amberg, Germany
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • Klinikum Bayreuth Bayreuth, Germany
  • Charité Universitätsmedizin Berlin Berlin, Germany
View all 79 locations
View Trial Details
Recruiting

- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

NCT06856837

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Ordensklinikum Linz GmbH Linz, Austria
  • SCRI CCCIT Ges.m.b.H. Salzburg, Austria
  • Noe LGA Gesundheit Thermenregion GmbH Wiener Neustadt, Austria
  • Klinikum St. Marien Amberg Amberg, Germany
View all 23 locations
View Trial Details
Recruiting

Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer

NCT06245356

Conditions
Colonic Diseases, Colorectal Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • CHU Amiens Amiens, France
  • Institut de Cancérologie de l'Ouest Angers, France
  • Institut du Cancer d'Avignon Avignon, France
  • CHU Jean Minjoz Besançon, France
View all 21 locations
View Trial Details
Recruiting

A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer

NCT05639413

Conditions
BRAF V600E Mutation Positive, Colonic Diseases, Colorectal Neoplasms, +10 more
Locations
  • Centre Hospitalier D'Avignon Avignon, France
  • Centre Hospitalier de Bayeux Bayeux, France
  • Chu Simone Veil Beauvais, France
  • Institut Bergonie Bordeaux, France
View all 45 locations
View Trial Details
Recruiting

FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.

NCT06733038

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Fondazione Poliambulanza, Istituto Ospedaliero Brescia, BS, Italy
  • Azienda Ospedaliero Universitaria Policlinico Rodolico - S. Marco Catania, CT, Italy
  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori Meldola, FC, Italy
  • Fondazione Casa Sollievo della Sofferenza San Giovanni Rotondo, FG, Italy
View all 24 locations
View Trial Details

Related conditions